Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

FDA Confirms It’s Moving Forward with New Phase of Mifepristone Safety Review

‘Every woman deserves the highest standard of medical care,’ said Carol Tobias, president of National Right to Life. ‘We encourage the agency to conduct this review with transparency, scientific integrity, and an unwavering commitment to protecting women.’

U.S. Supreme Court Issues Order Allowing Ongoing Mail-Order Abortion

The move comes after a federal appellate court issued a unanimous ruling earlier this month that – if allowed to take effect – would have blocked mail-order abortion nationwide.

23 States, Over 100 Lawmakers Call on U.S. Supreme Court to Block Mail-Order Abortion Pills

The filings come as a federal district court this month reinstated the in-person dispensing requirement for the abortion drug, thereby blocking mail-order abortion nationwide. The case has now gone before the Supreme Court.

Online Prescription of Abortion Drugs in Pro-Life States Rose 25% Last Year Amid Ongoing Lack of Regulations

The Guttmacher Institute’s latest report contributes to ongoing pro-life worries about the increased prevalence of abortion drugs nationwide, which undermines state laws and puts women and babies at risk.

Tagged abortion pillchemical abortionsFDAGuttmacher Institutehhsmifepristoneonline prescription